PRIVIA HEALTH GROUP INC (PRVA) Fundamental Analysis & Valuation

NASDAQ:PRVA • US74276R1023

Current stock price

20.02 USD
-0.16 (-0.79%)
At close:
20.02 USD
0 (0%)
After Hours:

This PRVA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. PRVA Profitability Analysis

1.1 Basic Checks

  • In the past year PRVA was profitable.
  • PRVA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
  • PRVA had a positive operating cash flow in each of the past 5 years.
PRVA Yearly Net Income VS EBIT VS OCF VS FCFPRVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • PRVA has a Return On Assets (1.67%) which is in line with its industry peers.
  • PRVA has a Return On Equity of 3.11%. This is comparable to the rest of the industry: PRVA outperforms 58.00% of its industry peers.
  • With a Return On Invested Capital value of 2.75%, PRVA perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
  • PRVA had an Average Return On Invested Capital over the past 3 years of 2.17%. This is significantly below the industry average of 8.74%.
  • The last Return On Invested Capital (2.75%) for PRVA is above the 3 year average (2.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROIC 2.75%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
PRVA Yearly ROA, ROE, ROICPRVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.08%, PRVA is in line with its industry, outperforming 57.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PRVA has declined.
  • With a Operating Margin value of 1.61%, PRVA perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of PRVA has declined.
  • PRVA has a worse Gross Margin (9.87%) than 75.00% of its industry peers.
  • PRVA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
PRVA Yearly Profit, Operating, Gross MarginsPRVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRVA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
  • Compared to 1 year ago, PRVA has more shares outstanding
  • Compared to 5 years ago, PRVA has more shares outstanding
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PRVA Yearly Shares OutstandingPRVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
PRVA Yearly Total Debt VS Total AssetsPRVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 4.12 indicates that PRVA is not in any danger for bankruptcy at the moment.
  • PRVA has a Altman-Z score of 4.12. This is in the better half of the industry: PRVA outperforms 78.00% of its industry peers.
  • There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.12
ROIC/WACC0.3
WACC9.08%
PRVA Yearly LT Debt VS Equity VS FCFPRVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • PRVA has a Current Ratio of 1.60. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.60, PRVA is doing good in the industry, outperforming 65.00% of the companies in the same industry.
  • A Quick Ratio of 1.60 indicates that PRVA should not have too much problems paying its short term obligations.
  • PRVA has a better Quick ratio (1.60) than 67.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
PRVA Yearly Current Assets VS Current LiabilitesPRVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PRVA Growth Analysis

3.1 Past

  • PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.55%, which is quite impressive.
  • Measured over the past years, PRVA shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.93% on average per year.
  • The Revenue has grown by 22.26% in the past year. This is a very strong growth!
  • PRVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.04% yearly.
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%

3.2 Future

  • Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 57.20% on average per year.
  • The Revenue is expected to grow by 10.44% on average over the next years. This is quite good.
EPS Next Y106.06%
EPS Next 2Y65.53%
EPS Next 3Y57.2%
EPS Next 5YN/A
Revenue Next Year13.79%
Revenue Next 2Y12.12%
Revenue Next 3Y11.91%
Revenue Next 5Y10.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. PRVA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 117.76, which means the current valuation is very expensive for PRVA.
  • PRVA's Price/Earnings ratio is in line with the industry average.
  • PRVA is valuated expensively when we compare the Price/Earnings ratio to 24.89, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 57.15, the valuation of PRVA can be described as expensive.
  • PRVA's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. PRVA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 117.76
Fwd PE 57.15
PRVA Price Earnings VS Forward Price EarningsPRVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRVA indicates a slightly more expensive valuation: PRVA is more expensive than 60.00% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PRVA indicates a somewhat cheap valuation: PRVA is cheaper than 73.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.15
EV/EBITDA 45.23
PRVA Per share dataPRVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PRVA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as PRVA's earnings are expected to grow with 57.20% in the coming years.
PEG (NY)1.11
PEG (5Y)N/A
EPS Next 2Y65.53%
EPS Next 3Y57.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PRVA Dividend Analysis

5.1 Amount

  • PRVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PRVA Fundamentals: All Metrics, Ratios and Statistics

PRIVIA HEALTH GROUP INC

NASDAQ:PRVA (3/27/2026, 8:00:01 PM)

After market: 20.02 0 (0%)

20.02

-0.16 (-0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners99.61%
Inst Owner Change0.49%
Ins Owners1.85%
Ins Owner Change5.21%
Market Cap2.48B
Revenue(TTM)2.12B
Net Income(TTM)22.92M
Analysts84.29
Price Target32.94 (64.54%)
Short Float %2.15%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)43.55%
Min EPS beat(2)-8.97%
Max EPS beat(2)96.08%
EPS beat(4)1
Avg EPS beat(4)-2.92%
Min EPS beat(4)-60.96%
Max EPS beat(4)96.08%
EPS beat(8)1
Avg EPS beat(8)-23.29%
EPS beat(12)3
Avg EPS beat(12)-1.19%
EPS beat(16)6
Avg EPS beat(16)61.33%
Revenue beat(2)1
Avg Revenue beat(2)5.86%
Min Revenue beat(2)-6.18%
Max Revenue beat(2)17.91%
Revenue beat(4)3
Avg Revenue beat(4)4.55%
Min Revenue beat(4)-6.18%
Max Revenue beat(4)17.91%
Revenue beat(8)7
Avg Revenue beat(8)4.33%
Revenue beat(12)10
Avg Revenue beat(12)3.07%
Revenue beat(16)10
Avg Revenue beat(16)-7.25%
PT rev (1m)2.44%
PT rev (3m)2.36%
EPS NQ rev (1m)11.77%
EPS NQ rev (3m)11.77%
EPS NY rev (1m)8.83%
EPS NY rev (3m)9.32%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)-31.33%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)-37.78%
Valuation
Industry RankSector Rank
PE 117.76
Fwd PE 57.15
P/S 1.17
P/FCF 15.15
P/OCF 15.15
P/B 3.36
P/tB 7.95
EV/EBITDA 45.23
EPS(TTM)0.17
EY0.85%
EPS(NY)0.35
Fwd EY1.75%
FCF(TTM)1.32
FCFY6.6%
OCF(TTM)1.32
OCFY6.6%
SpS17.16
BVpS5.96
TBVpS2.52
PEG (NY)1.11
PEG (5Y)N/A
Graham Number4.77
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 3.11%
ROCE 4.27%
ROIC 2.75%
ROICexc 6.87%
ROICexgc N/A
OM 1.61%
PM (TTM) 1.08%
GM 9.87%
FCFM 7.7%
ROA(3y)1.75%
ROA(5y)-4.65%
ROE(3y)3.16%
ROE(5y)-7.26%
ROIC(3y)2.17%
ROIC(5y)N/A
ROICexc(3y)6.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.37%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-16.37%
OM growth 3YN/A
OM growth 5Y-12.3%
PM growth 3YN/A
PM growth 5Y-22.33%
GM growth 3Y-0.24%
GM growth 5Y-0.49%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 136.39
Cash Conversion 370.18%
Profit Quality 712.96%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 4.12
F-Score6
WACC9.08%
ROIC/WACC0.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)607.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.55%
EPS 3Y9.35%
EPS 5Y-9.93%
EPS Q2Q%133.33%
EPS Next Y106.06%
EPS Next 2Y65.53%
EPS Next 3Y57.2%
EPS Next 5YN/A
Revenue 1Y (TTM)22.26%
Revenue growth 3Y16.09%
Revenue growth 5Y21.04%
Sales Q2Q%-31.71%
Revenue Next Year13.79%
Revenue Next 2Y12.12%
Revenue Next 3Y11.91%
Revenue Next 5Y10.44%
EBIT growth 1Y101.6%
EBIT growth 3YN/A
EBIT growth 5Y6.15%
EBIT Next Year470.08%
EBIT Next 3Y100.08%
EBIT Next 5Y56.77%
FCF growth 1Y49.53%
FCF growth 3Y51.38%
FCF growth 5Y33.52%
OCF growth 1Y49.53%
OCF growth 3Y51.28%
OCF growth 5Y33.26%

PRIVIA HEALTH GROUP INC / PRVA Fundamental Analysis FAQ

What is the fundamental rating for PRVA stock?

ChartMill assigns a fundamental rating of 5 / 10 to PRVA.


Can you provide the valuation status for PRIVIA HEALTH GROUP INC?

ChartMill assigns a valuation rating of 3 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.


Can you provide the profitability details for PRIVIA HEALTH GROUP INC?

PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for PRVA stock?

The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 117.76 and the Price/Book (PB) ratio is 3.36.


Can you provide the financial health for PRVA stock?

The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.